Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harris Markomanolaki

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 6, 2007
Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cellsGalatea Kallergi, Sofia Agelaki, Harris Markomanolaki, et al.
Biodiversity Data Journal|June 29, 2026
Population-level transcriptomic datasets from two benthic invertebrates exposed to long-term experimental warming and acidificationElisavet Kaitetzidou, Harris Markomanolaki, Francesco Fabiano, et al.
Cancer Biology & Therapy|June 2, 2009
Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibitionSophia Agelaki, Maria Spiliotaki, Harris Markomanolaki, et al.
Molecular Cancer Therapeutics|June 20, 2013
Apoptotic circulating tumor cells in early and metastatic breast cancer patientsGalatea Kallergi, Georgios Konstantinidis, Harris Markomanolaki, et al.
Plos One|June 18, 2015
Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast CancerSofia Agelaki, Antonia Kalykaki, Harris Markomanolaki, et al.
Breast Cancer Research : BCR|November 30, 2014
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancyMaria Spiliotaki, Dimitris Mavroudis, Kyriaki Kapranou, et al.
Breast Cancer Research : BCR|November 19, 2009
Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patientsGalatea Kallergi, Harris Markomanolaki, Vicky Giannoukaraki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 6, 2007
Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cellsGalatea Kallergi, Sofia Agelaki, Harris Markomanolaki, et al.
Biodiversity Data Journal|June 29, 2026
Population-level transcriptomic datasets from two benthic invertebrates exposed to long-term experimental warming and acidificationElisavet Kaitetzidou, Harris Markomanolaki, Francesco Fabiano, et al.
Cancer Biology & Therapy|June 2, 2009
Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibitionSophia Agelaki, Maria Spiliotaki, Harris Markomanolaki, et al.
Molecular Cancer Therapeutics|June 20, 2013
Apoptotic circulating tumor cells in early and metastatic breast cancer patientsGalatea Kallergi, Georgios Konstantinidis, Harris Markomanolaki, et al.
Plos One|June 18, 2015
Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast CancerSofia Agelaki, Antonia Kalykaki, Harris Markomanolaki, et al.
Breast Cancer Research : BCR|November 30, 2014
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancyMaria Spiliotaki, Dimitris Mavroudis, Kyriaki Kapranou, et al.
Breast Cancer Research : BCR|November 19, 2009
Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patientsGalatea Kallergi, Harris Markomanolaki, Vicky Giannoukaraki, et al.
Pageof 1